National Institute of Neurological Disorders and Stroke (NINDS) Parkinson's Disease Neuroprotection Trial
Completed · Phase 2
Conditions studied: Parkinson's Disease
In brief
The goal of this study is to assess the impact of minocycline and creatine on the progression of Parkinson's disease, in order to determine whether it is reasonable to proceed with further study of either of these agents.
Key facts
- Study ID
- NCT00063193
- Run by
- University of Rochester
- People needed
- 195
- Starts
- 2003-05-01
- Expected to finish
- 2005-07-01
- Last updated by the study team
- 2016-01-20
Who can join
Age: 30 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University of Rochester Medical Center — Rochester, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.